NZ237447A - Plasmodium sporozoite antigen, dna, vectors, transformed microorganisms and preparation, immunogenic compositions and polypeptides containing epitopes of the antigen - Google Patents

Plasmodium sporozoite antigen, dna, vectors, transformed microorganisms and preparation, immunogenic compositions and polypeptides containing epitopes of the antigen

Info

Publication number
NZ237447A
NZ237447A NZ237447A NZ23744791A NZ237447A NZ 237447 A NZ237447 A NZ 237447A NZ 237447 A NZ237447 A NZ 237447A NZ 23744791 A NZ23744791 A NZ 23744791A NZ 237447 A NZ237447 A NZ 237447A
Authority
NZ
New Zealand
Prior art keywords
antigen
vectors
dna
preparation
immunogenic compositions
Prior art date
Application number
NZ237447A
Inventor
Ulrich Certa
Maria Guttinger
Hugues Matile
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NZ237447A publication Critical patent/NZ237447A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NZ237447A 1990-03-23 1991-03-15 Plasmodium sporozoite antigen, dna, vectors, transformed microorganisms and preparation, immunogenic compositions and polypeptides containing epitopes of the antigen NZ237447A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH97090 1990-03-23

Publications (1)

Publication Number Publication Date
NZ237447A true NZ237447A (en) 1993-05-26

Family

ID=4199439

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ237447A NZ237447A (en) 1990-03-23 1991-03-15 Plasmodium sporozoite antigen, dna, vectors, transformed microorganisms and preparation, immunogenic compositions and polypeptides containing epitopes of the antigen

Country Status (9)

Country Link
EP (1) EP0447956A1 (en)
JP (1) JPH0686679A (en)
AU (1) AU637468B2 (en)
CA (1) CA2037151A1 (en)
IE (1) IE910966A1 (en)
IL (1) IL97578A0 (en)
NZ (1) NZ237447A (en)
PT (1) PT97117A (en)
ZA (1) ZA911950B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3355095A (en) * 1994-09-02 1996-03-27 Meiji Milk Products Company Limited Diagnostic drug for chlamydia infection
EP1221968B1 (en) * 1999-10-13 2010-01-13 Novartis Vaccines and Diagnostics, Inc. Method of obtaining cellular immune responses from proteins
CA2713879C (en) * 2008-02-01 2020-01-07 Alpha-O Peptides Ag Self-assembling peptide nanoparticles useful as vaccines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE78869T1 (en) * 1985-02-07 1992-08-15 Smithkline Beecham Corp MALARIA VACCINE.
GB8615068D0 (en) * 1986-06-20 1986-07-23 Wellcome Found Vaccines
HUT51332A (en) * 1987-01-30 1990-04-28 Smithkline Biolog Process for expressing p.falciparum cirkumsporozoita protein by yeast
AU625713B2 (en) * 1988-02-19 1992-07-16 Microgenesys, Inc. Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
FR2645877B1 (en) * 1989-04-12 1991-07-05 Pasteur Institut MOLECULES COMPRISING AT LEAST ONE PEPTIDE SEQUENCE CARRYING ONE, OR SEVERAL, CHARACTERISTIC EPITOPE OF A PROTEIN PRODUCED BY P. FALCIPARUM AT THE SPOROZOITE STAGE AND IN THE HEPATOCYTES
AU7163091A (en) * 1989-12-12 1991-07-18 Biomedical Research Institute Novel malarial sporozoite peptide antigens

Also Published As

Publication number Publication date
CA2037151A1 (en) 1991-09-24
ZA911950B (en) 1991-11-27
AU637468B2 (en) 1993-05-27
PT97117A (en) 1991-11-29
IL97578A0 (en) 1992-06-21
JPH0686679A (en) 1994-03-29
AU7358991A (en) 1991-10-03
EP0447956A1 (en) 1991-09-25
IE910966A1 (en) 1991-09-25

Similar Documents

Publication Publication Date Title
ZA913291B (en) Hair-treating microemulsion composition and method of preparing and using the same
IL105770A0 (en) Vaccine compositions and their preparation
GB8924438D0 (en) Vaccine composition
HK1000113A1 (en) Vaccine composition
IL70776A (en) Recombinant dna molecule encoding at least one polypeptide displaying the immunogenicity of at least one merozoite antigen or asexual blood stage antigen of p.falciparum,vectors comprising the dna molecule,host cells transformed thereby,immunogenic polypeptides produced by host cells and compositions containing the polypeptides
IL98845A0 (en) Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties,their preparation and pharmaceutical compositions containing them
NZ233085A (en) Eimeria tenella 100kd immunogenic peptide, vectors, antibodies and vaccines
IL102448A0 (en) Immunogenic polypeptide,its production and coccidiosis vaccine containing it
NZ234049A (en) Peptide epitopes of, and antibodies to htlv-1
NZ237447A (en) Plasmodium sporozoite antigen, dna, vectors, transformed microorganisms and preparation, immunogenic compositions and polypeptides containing epitopes of the antigen
EP0290565A4 (en) Vaccine containing tick antigens.
IL71953A (en) Malaria associated antigen,process for preparation thereof and vaccine comprising it
ZA916433B (en) Novel pyrrolobenzimidazoles,imidazobenzoxazinones and imidazoquinolones,process for their preparation and their use and preparations containing the compounds
AP9000165A0 (en) Vaccine composition
ZA874920B (en) Immunogenic fraction active against bilharzioses,its preparation,and immunizing compositions containing it
NZ223624A (en) Peptide immunogen from streptococcus mutans, vaccines and antibodies
IL81920A (en) Vaccines comprising an antigen and interferon-ypsilon and their preparation
NZ233255A (en) Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope
IL104745A0 (en) 90k tumor-associated antigen,method for the preparation thereof and pharmaceutical compositions containing the same
GB8919064D0 (en) Plasmodium merozoite rhoptries antigen
IL93589A0 (en) Bisphenethanolamine,its preparation and preparations containing it
HU9201115D0 (en) Alchemilla-extract, process for its preparation, and cosmetical preparations made of alchemilla extract
GB2238959B (en) Antigen and conjugates thereof for suppressing immune response
GB8700406D0 (en) Babesia divergens antigen & vaccine
GB2248186B (en) Preparation of vaccines